Proceedings for Annual Meeting of The Japanese Pharmacological Society
Online ISSN : 2435-4953
The 95th Annual Meeting of the Japanese Pharmacological Society
Session ID : 95_2-O-088
Conference information

Oral Sessions
Erk5 in mesenchymal stem cells maintains bone homeostasis in adulthood
*Tetsuhiro HorieKazuya FukasawaTakanori YamadaTakashi IezakiEiichi Hinoi
Author information
CONFERENCE PROCEEDINGS OPEN ACCESS

Details
Abstract

We previously clarified that Extracellular signal-regulated kinase 5 (Erk5) directly phosphorylates Smad specific E3 ubiquitin protein ligase 2 (Smurf2) at Thr249 (Smurf2Thr249), which leads to activating its ubiquitin ligase activity. Although we have demonstrated that Erk5 in embryonic mesenchymal stem cells (MSCs) is necessary for proper skeletogenesis, its role in adult bone marrow (BM)-MSCs on bone homeostasis remains unknown. It has been reported that Leptin receptor-positive (LepR+) BM-MSCs represent a major source of bone in adult bone marrow. Here, we unveiled the importance of Erk5 in BM-MSCs as a critical regulator of bone homeostasis in adulthood. Mice lacking Erk5 in LepR+ BM-MSCs showed osteosclerotic bone marrow with age in vivo. Erk5 deficiency increased differentiation of BM-MSCs toward osteoblasts along with a higher expression of transcription factors for osteogenic differentiation in vitro. Erk5 deficiency decreased Smurf2Thr249 phosphorylation, and subsequently increased Smad1/5/8-dependent signaling in BM-MSCs. Genetic induction of the phosphomimetic mutant of Smurf2 rescued the osteosclerotic phenotype in Erk5-deficient mice. These findings suggest that the Erk5–Smurf2Thr249 axis in BM-MSCs plays an essential role in maintaining proper bone homeostasis in adult bone marrow.

Content from these authors
© 2022 The Authors(s)
Previous article Next article
feedback
Top